UNSPSC 85893204: Low dose rate (ldr) brachytherapy of rectum using iodine 125 (i-125)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of low dose rate (ldr) brachytherapy of rectum using iodine 125 (i-125). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DD17B9Z

UNSPSC 85893204 Low dose rate brachytherapy of rectum using iodine 125, a Commodity code, shows a significant mismatch between its nominal scope and actual state and local procurement activity. The code's technical description refers to a highly specialized oncology procedure — low-dose-rate internal radiation therapy targeting rectal cancer — yet the single recent opportunity on record is a temporary health professional staffing RFQ posted by the County of Santa Clara Health System seeking vendors to fill ancillary clinical roles such as audiology, cardiology support, diagnostic imaging, gastroenterology, respiratory care, surgical/operating room services, and therapy services. The staffing solicitation contains no reference to brachytherapy, cancer treatment, or any oncology-specific service line and appears to have been miscoded or tagged by the issuing body.

The County of Santa Clara Health System's temporary staffing RFQ, posted July 7, 2026 with responses due October 7, 2026, establishes a non-exclusive multiple-award qualified vendor pool with no guaranteed volume and a five-year term. The Health System explicitly excludes nursing, physician, and other non-clinical staffing from the solicitation and will negotiate scope of services case-by-case with selected vendors. California shows the only recent activity under this code. The mismatch between the code's clinical specificity and the generalist staffing work actually being solicited suggests either systematic miscoding by Santa Clara County or a data classification error in the UNSPSC taxonomy itself. This code presents minimal relevant opportunity for vendors focused on brachytherapy products, equipment, or specialized oncology clinical services.